FDA approves Emergent BioSolutions' anthrax vaccine

FDA approves Emergent BioSolutions' anthrax vaccine

Source: 
Reuters
snippet: 

Emergent BioSolutions (EBS.N) said on Thursday the U.S. Food and Drug Administration has approved its anthrax vaccine for use in adults aged 18 through 65.